Lithium ions are absorbed rapidly and com pletely when given orally (Amdisen and Schou, 1967) , the only route of administration used in SjOgren, 1968) .
Lithium enters the cells. Equilibration is rapid with some tissues, e.g. liver and kidney, and slow with others, such as muscle, bone and brain;
full equilibration takes about a week.
The lithium concentration in brain (expressed in meq/kg. wet weight) is at equilibrium ap proximately the same as in blood plasma or serum (expressed as meq/l). Lithium is not bound to plasma or tissue proteins. The main route of lithium elimination is through the kidneys; only small amounts leave the body with faeces and sweat. Renal lithium excretion is proportional to the plasma con centration within a wide concentration range, i.e. the renal lithium clearance is independent of the blood level. About four-fifths of the filtered lithium is reabsorbed in the tubules and one fifth excreted in the urine. Reabsorption takes place mainly or exclusively in the proximal tubules, possibly by the mechanism responsible for reabsorption of sodium in this segment (Thomsen and Schou, 1968) .
The renal lithium clearance is remarkably constant, with little day-to-day or month-to month variation.
It is unaffected by water loading as well as by the administration of a number of diuretics, but may be increased through the production of osmotic diuresis, by alkalinization of the urine with acetazolamide or sodium bicarbonate, and by administration of aminophylline. The clearance decreases when the sodium intake is severely restricted.
Administration, dosage, and control
Full prophylactic effect of lithium treatment is in most patients obtained only when the One is represented by side effects that may be seen at low serum lithium concentrations and which are incon venient rather than dangerous. The other is the lithium intoxication associated with accumu lation of lithium to serum levels above 2 meq/l.
Side effects
During the first 1â€"2 weeks of the treatment slight side effects are frequent, but they usually disappear on continued lithium administration. Some side effects may persist or appear at a later stage; they are also fully reversible and disappear when lithium is discontinued. Table   I , 1965; Buhl and Hansen, 1968; Schou ci a!., Ig68b ; AllgÃ©n, , 969 asymmetrical, the condition has occasionally been misdiagnosed as a cerebral haemorrhage. Death may result from pulmonary complications.
The diagnosis of lithium poisoning is estab lished by the demonstration of serum lithium values above 2â€"3meq/1, but the result of the blood analysis must be evaluated with considera tion of the gradual decline of serum lithium after discontinuation of the drug. The serum concentration usually falls by one-half every 1â€"2 days, and intoxication symptoms may per sisteven when serum lithium has fallen below 1â€"2 meq/l. During prophylactic treatment there are no symptoms to remind the patients to take their medicine, and negligence on this point is a frequent cause of relapse. The patients must be urged to strict tablet discipline for maximum protection through the treatment.
Patients may want to discontinue lithium treatment for various reasons. Side effects are not a frequent cause, but weight gain has occasionally discouraged patients from con tinuing. Some patients may in the beginning object to the treatment because they miss the traditional hypomanic bursts of inspiration and indefatigability; in most cases, however, the avoidance of depressive relapses is a suffi cient compensation, so that they continue. The appearance of a relapse, particularly a depressive one, may lead patients to discontinue treatment. It should be noted, however, that the onset of the prophylactic effect is often gradual so that relapses may occur during the first months, although with decreasing intensity, duration and frequency. Prophylactic lithium treatment should not be given up as valueless before the drug has been administered in proper dosage for at least six months.
The non-appearance of relapses may also induce patients to stop taking lithium. After some time they feel that the disease must now have ceased and want to be without medicine. However, manic and depressive relapses appear with the same frequency and duration after discontinuation of lithium as before the treat ment was started (Baastrup and Schou, 1967) ANosv, J., Wars, P., GROF, P., B@sri@up, P. C., and
ScHou, M. (1970). â€oe¿ Lithiumprophylaxis in recurrent

